Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 8/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.81 |
| ▸ | MEN1 | O00255 | 8/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.81 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.81 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.81 |
| ▸ | FTO | Q9C0B1 | 6/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.81 |
| ▸ | XDH | P47989 | 6/20 | 0.81 |
| ▸ | MAPT | P10636 | 5/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.81 |
| ▸ | APP | P05067 | 5/20 | 0.81 |
| ▸ | BCHE | P06276 | 4/20 | 0.81 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.81 |
| ▸ | ACHE | P22303 | 4/20 | 0.81 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.81 |
| ▸ | CA12 | O43570 | 4/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919099 | 0.90 | MEN1 (0.65) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL18817 | 0.90 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL1259228 | 0.90 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL29378805 | 0.90 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL30655455 | 0.90 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL38651062 | 0.88 | MEN1 (0.97) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL31749037 | 0.88 | MEN1 (0.97) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL34461912 | 0.88 | MEN1 (0.97) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL31256029 | 0.88 | MEN1 (0.97) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Kaempferol SCHEMBL31577746 | 0.88 | MEN1 (0.97) | ABCB1CYP1A2MEN1KMT2ACYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346737-A1 | COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF VIRUS INFECTIONS | Arjil Biotech Holding Company Limited (TW) | 2023-11-02 | — | — | US | disclosed |
| US-20230200388-A1 | COMPOUNDS AND METHODS FOR STIMULATING PLANTS | Sound Agriculture Company (US) | 2023-06-29 | — | — | US | disclosed |
| EP-3007713-B1 | OILY EXTRACT OF PLANTS OF RUBUS SPECIES AND USES THEREOF IN MEDICAL AND COSMETIC FIELDS | MEDICINA VEGETALE TRADIZIONALE GROUP S R L (IT) | 2019-10-23 | — | — | EP | disclosed |
| US-9295664-B2 | Methods for lowering blood glucose | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2016-03-29 | — | — | US | disclosed |
| US-8865779-B2 | Compounds, compositions, and methods for reducing or eliminating bitter taste | CHROMOCELL CORPORATION (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140147537-A1 | FRUIT EXTRACTS | PROVEXIS NATURAL PRODUCTS LIMITED (GB) | 2014-05-29 | — | — | US | disclosed |
| US-8426568-B2 | Rhamnose substituents of SL0101 and therapeutic uses thereof | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2013-04-23 | — | — | US | disclosed |
| US-20110206794-A1 | FRUIT EXTRACTS | PROVEXIS NATURAL PRODUCTS LIMITED (GB) | 2011-08-25 | — | — | US | disclosed |
| US-20110190514-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | LIMERICK BIOPHARMA, INC. (US) | 2011-08-04 | — | — | US | disclosed |
| US-7947733-B2 | Phosphorylated pyrone analogs and methods | LIMERICK BIOPHARMA (US) | 2011-05-24 | — | — | US | disclosed |
| US-20100297020-A1 | PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2010-11-25 | — | — | US | disclosed |
| US-20100204089-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | LIMERICK BIOPHARMA, INC. | 2010-08-12 | — | — | US | disclosed |
| US-20100189653-A1 | Pyrone analogs for therapeutic treatment | LIMERICK BIOPHARMA, INC. | 2010-07-29 | — | — | US | disclosed |
| US-20100144612-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | LIMERICK BIOPHARMA, INC. | 2010-06-10 | — | — | US | disclosed |
| US-20100016245-A1 | RHAMNOSE SUBSTITUENTS OF SL0101 AND THERAPEUTIC USES THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2010-01-21 | — | — | US | disclosed |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | LIMERICK BIOPHARMA, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090258939-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | LIMERICK BIOPHARMA, INC. | 2009-10-15 | — | — | US | disclosed |
| US-20090082400-A1 | SOLUBLE PYRONE ANALOGS METHODS AND COMPOSITIONS | LIMERICK BIOPHARMA, INC. | 2009-03-26 | — | — | US | disclosed |
| US-20090069273-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | LIMERICK BIOPHARMA, INC. | 2009-03-12 | — | — | US | disclosed |
| US-20080152735-A1 | Herbal Extract Having Anti- Influenza Virus Activity and Preparation of Same | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016245-A1 | RHAMNOSE SUBSTITUENTS OF SL0101 AND THERAPEUTIC USES THEREOF | SPHK1, SGPL1, SRPK1 | ABCB1 1704/4885CYP1A2 3347/4885MEN1 3169/4885 |
| US-20090069273-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | PCK1, PC, PCK2 | ABCB1 29/4885CYP1A2 832/4885MEN1 4072/4885 |
| US-20110206794-A1 | FRUIT EXTRACTS | F3, NEU3, GP6 | ABCB1 762/4885CYP1A2 2231/4885MEN1 4543/4885 |
| US-20090258939-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | CYP11B2, CYP11B1, GLS2 | ABCB1 1830/4885CYP1A2 817/4885MEN1 535/4885 |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | SLC2A1, SLC2A2, SLC2A3 | ABCB1 252/4885CYP1A2 3381/4885MEN1 4409/4885 |
| US-20230200388-A1 | COMPOUNDS AND METHODS FOR STIMULATING PLANTS | SNRK, GRK1, PPIP5K2 | ABCB1 4561/4885CYP1A2 4273/4885MEN1 3498/4885 |
| US-20100297020-A1 | PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT | PC, PCK1, PYGL | ABCB1 1417/4885CYP1A2 2311/4885MEN1 2302/4885 |
| US-20140147537-A1 | FRUIT EXTRACTS | F3, NEU3, GP6 | ABCB1 672/4885CYP1A2 2204/4885MEN1 4467/4885 |
| US-20100189653-A1 | Pyrone analogs for therapeutic treatment | PC, GLS2, CYP27A1 | ABCB1 540/4885CYP1A2 614/4885MEN1 1731/4885 |
| US-20100144612-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | PCK1, PC, PCK2 | ABCB1 29/4885CYP1A2 832/4885MEN1 4072/4885 |
| US-20100204089-A1 | PHOSPHORYLATED PYRONE ANALOGS AND METHODS | PCK1, PC, PCK2 | ABCB1 29/4885CYP1A2 832/4885MEN1 4072/4885 |
| US-20110190514-A1 | PYRONE ANALOG COMPOSITIONS AND METHODS | CYP11B2, CYP11B1, GLS2 | ABCB1 1830/4885CYP1A2 817/4885MEN1 535/4885 |
| US-20090082400-A1 | SOLUBLE PYRONE ANALOGS METHODS AND COMPOSITIONS | PGF, ABCG2, PYGB | ABCB1 16/4885CYP1A2 97/4885MEN1 3857/4885 |
| US-20230346737-A1 | COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF VIRUS INFECTIONS | SLC10A1, HAVCR2, ACE2 | ABCB1 47/4885CYP1A2 1031/4885MEN1 2909/4885 |
| US-20080152735-A1 | Herbal Extract Having Anti- Influenza Virus Activity and Preparation of Same | AGO2, MAVS, NOTUM | ABCB1 1400/4885CYP1A2 814/4885MEN1 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.